Jefferies Raises Numbers On Omega Healthcare Investors (OI) After Q4 Results
OHI Hot Sheet
Rating Summary:2 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38
Jefferies raised estimates and its price target on Omega Healthcare Investors (NYSE: OHI) from $21 to $24 following Q4 results, which the firm said sets up for strong 2012 performance.
Q1 EPS goes from $0.47 to $0.51, FY12 from $1.91 to $2.04 and FY13 from $1.98 to $2.10.
The firm comments, "We believe OHI shares are undervalued at current levels. Medicare reimbursement trends for skilled nursing remains an overhang, but it appears operators are adjusting to rate cuts better-than-expected. As such, we believe risk of tenant rent defaults at OHI is low. We reiterate our Buy rating on OHI shares."
For an analyst ratings summary and ratings history on Omega Healthcare Investors click here. For more ratings news on Omega Healthcare Investors click here.
Shares of Omega Healthcare Investors closed at $21.84 yesterday, with a 52 week range of $14.40-$24.46.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Q1 EPS goes from $0.47 to $0.51, FY12 from $1.91 to $2.04 and FY13 from $1.98 to $2.10.
The firm comments, "We believe OHI shares are undervalued at current levels. Medicare reimbursement trends for skilled nursing remains an overhang, but it appears operators are adjusting to rate cuts better-than-expected. As such, we believe risk of tenant rent defaults at OHI is low. We reiterate our Buy rating on OHI shares."
For an analyst ratings summary and ratings history on Omega Healthcare Investors click here. For more ratings news on Omega Healthcare Investors click here.
Shares of Omega Healthcare Investors closed at $21.84 yesterday, with a 52 week range of $14.40-$24.46.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Barclays Maintains an 'Equalweight' on J. C. Penney (JCP); Slashing PT on Disappointing Results
- Deutsche Bank Cuts Price Target and EPS Estimates on J. C. Penney (JCP); There's Only Two Ways This Can Go
- Nomura Securities Raises PT and Estimates on PetSmart (PETM) After Good Q1
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
